Target: Phosphorylated PERK (Thr981) in humans, mice, and rats .
Host Species: Mouse or Rabbit , depending on the product.
Clonality: Monoclonal (single epitope specificity) .
Immunogen: Synthesized peptide derived from human PERK around Thr981 .
Reactivity: Human, Mouse, Rat .
Applications:
Specificity: Binds exclusively to PERK phosphorylated at Thr981, validated via peptide blocking assays .
Western Blot: Detected PERK phosphorylation in HeLa, AD293, and 453 cell lines under ER stress . Thapsigargin and tunicamycin treatments increased phosphorylation levels .
Immunofluorescence: Showed ER membrane localization in cervical carcinoma cells, consistent with PERK’s role in ER stress .
Tissue Staining: Positive signals in rat heart, kidney, and human prostate carcinoma tissues .
| Species Reactivity | Validation Method | Source |
|---|---|---|
| Human | IF, IHC, WB | |
| Mouse | IHC (kidney tissue) | |
| Rat | WB, IHC (lung/heart) |
Wolcott-Rallison Syndrome: Linked to EIF2AK3 (PERK) mutations .
Cancer: Overexpression observed in cervical and prostate carcinomas .
Diabetes: ER stress in pancreatic β-cells correlates with PERK activation .
Brain and Pancreas: PERK expression confirmed via PubMed IDs 14702039 and 10677345 .
Liver and Testis: Detected in studies (PubMed ID: 10026192) .